Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of $126.84 billion. The enterprise value is $137.42 billion.
| Market Cap | 126.84B |
| Enterprise Value | 137.42B |
Important Dates
The next confirmed earnings date is Thursday, July 25, 2024, before market open.
| Earnings Date | Jul 25, 2024 |
| Ex-Dividend Date | May 9, 2024 |
Share Statistics
Sanofi has 2.51 billion shares outstanding. The number of shares has decreased by -0.12% in one year.
| Shares Outstanding | 2.51B |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 10.35% |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 25.70 and the forward PE ratio is 11.14. Sanofi's PEG ratio is 0.84.
| PE Ratio | 25.70 |
| Forward PE | 11.14 |
| PS Ratio | 2.46 |
| Forward PS | 2.74 |
| PB Ratio | 1.57 |
| P/FCF Ratio | 14.12 |
| PEG Ratio | 0.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.63, with an EV/FCF ratio of 15.30.
| EV / Earnings | 22.90 |
| EV / Sales | 2.66 |
| EV / EBITDA | 9.63 |
| EV / EBIT | 15.18 |
| EV / FCF | 15.30 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.27 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.41 |
| Debt / FCF | 2.23 |
| Interest Coverage | 6.33 |
Financial Efficiency
Return on equity (ROE) is 7.30% and return on invested capital (ROIC) is 6.57%.
| Return on Equity (ROE) | 7.30% |
| Return on Assets (ROA) | 4.30% |
| Return on Capital (ROIC) | 6.57% |
| Revenue Per Employee | $599,438 |
| Profits Per Employee | $69,696 |
| Employee Count | 86,088 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, Sanofi has paid $1.74 billion in taxes.
| Income Tax | 1.74B |
| Effective Tax Rate | 22.52% |
Stock Price Statistics
The stock price has decreased by -5.86% in the last 52 weeks. The beta is 0.41, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -5.86% |
| 50-Day Moving Average | 49.04 |
| 200-Day Moving Average | 48.73 |
| Relative Strength Index (RSI) | 57.62 |
| Average Volume (20 Days) | 2,747,459 |
Short Selling Information
| Short Interest | 8.07M |
| Short Previous Month | 7.82M |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.73% |
| Short Ratio (days to cover) | 3.66 |
Income Statement
In the last 12 months, Sanofi had revenue of $51.60 billion and earned $6.00 billion in profits. Earnings per share was $2.34.
| Revenue | 51.60B |
| Gross Profit | 35.07B |
| Operating Income | 8.57B |
| Pretax Income | 7.62B |
| Net Income | 6.00B |
| EBITDA | 14.27B |
| EBIT | 9.05B |
| Earnings Per Share (EPS) | $2.34 |
Balance Sheet
The company has $9.48 billion in cash and $20.06 billion in debt, giving a net cash position of -$10.57 billion or -$4.22 per share.
| Cash & Cash Equivalents | 9.48B |
| Total Debt | 20.06B |
| Net Cash | -10.57B |
| Net Cash Per Share | -$4.22 |
| Equity (Book Value) | 80.62B |
| Book Value Per Share | 32.17 |
| Working Capital | 7.03B |
Cash Flow
In the last 12 months, operating cash flow was $11.17 billion and capital expenditures -$2.19 billion, giving a free cash flow of $8.98 billion.
| Operating Cash Flow | 11.17B |
| Capital Expenditures | -2.19B |
| Free Cash Flow | 8.98B |
| FCF Per Share | $3.59 |
Margins
Gross margin is 67.96%, with operating and profit margins of 16.62% and 11.63%.
| Gross Margin | 67.96% |
| Operating Margin | 16.62% |
| Pretax Margin | 14.77% |
| Profit Margin | 11.63% |
| EBITDA Margin | 27.66% |
| EBIT Margin | 17.54% |
| FCF Margin | 17.40% |
Dividends & Yields
This stock pays an annual dividend of $2.04, which amounts to a dividend yield of 4.02%.
| Dividend Per Share | $2.04 |
| Dividend Yield | 4.02% |
| Dividend Growth (YoY) | 7.20% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 86.98% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 4.14% |
| Earnings Yield | 4.73% |
| FCF Yield | 7.08% |
Analyst Forecast
The average price target for Sanofi is $55.00, which is 8.65% higher than the current price. The consensus rating is "Hold".
| Price Target | $55.00 |
| Price Target Difference | 8.65% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 4.98% |
| EPS Growth Forecast (5Y) | 39.51% |
Stock Splits
The last stock split was on September 30, 2013. It was a forward split with a ratio of 5:1.
| Last Split Date | Sep 30, 2013 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |